HDB's
GPCR solution provides a platform to speed up your
drug discovery/development.
G-protein
coupled receptors (GPCRs) are the most heavily investigated
targets in the pharmaceutical industry. It is commonly
remarked that 30-50% of marketed drugs are directed
against GPCRs as targets, with another 400 or so currently
in the pipeline. GPCRs represent a particularly active
area of development for cell-based functional assays
and other discovery activities.
As
a leader in GPCR research and development from the
fast-growing Chinese biotech/pharmaceutical industry,
HDB offers comprehensive solutions to address all
your needs in GPCR drug discovery/development. Our
products and services include:
